$3.77
0.58[18.18%]
Last update: 4:03PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$3.77
0[0.00%]
| Open3.360 | Close3.280 |
| Vol / Avg.22.352K / 32.019K | Mkt Cap47.877M |
| Day Range3.100 - 3.360 | 52 Wk Range2.800 - 6.190 |
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Gain Therapeutics Stock (NASDAQ:GANX), Key Statistics
Gain Therapeutics Stock (NASDAQ: GANX) analysis, key statistics.
Valuation Measures
Enterprise Value
26.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
694.92
Price / Book (mrq)
3.65
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-57.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.87
Tangible Book value per share
0.86
Total Liabilities (Quarterly)
7.2M
Total Assets
18.3M
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -